IRD Q1 2023 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$4M-219.9% margin

Operating Income

-$6M-350.5% margin

Net Income

-$6M-331.1% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-95.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$804,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$4M

Stockholders' Equity

$41M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$4M	$0	—
Operating Income	-$6M	-$7M	+5.8%
Net Income	-$6M	-$7M	+12.2%